Article Sidebar

Published: 2026-06-16
Abstract Views: 83
DOI: https://doi.org/10.52163/yhc.v67iCD6.5336
Issue
Vol. 67 No. CĐ6-NCKH
Section
Articles
How to Cite
Sơn, T. N., Hưng, Đỗ B., Huyền, V. T., & Bình, H. T. H. (2026). TOPICAL STEROID USE IN THE TREATMENT OF RHINOSINUSITIS IN PREGNANT WOMEN: A SCOPING REVIEW . Vietnam Journal of Community Medicine, 67(CĐ6-NCKH). https://doi.org/10.52163/yhc.v67iCD6.5336

TOPICAL STEROID USE IN THE TREATMENT OF RHINOSINUSITIS IN PREGNANT WOMEN: A SCOPING REVIEW

Tran Ngoc Son1, Do Ba Hung2, Van Thu Huyen1, Hoang Thi Hoa Binh2
1 Bao Yen Regional Medical Center, Lao Cai
2 Hanoi Medical University

Main Article Content

Abstract

Objective: To analyze the characteristics of studies on the use of topical steroids in the treatment of rhinosinusitis in pregnant women, and to describe the treatment outcomes and safety of topical steroid use during pregnancy.


Subjects and Methods: This scoping review included studies retrieved from electronic databases and information sources such as PubMed, Google Scholar, and the library of Hanoi Medical University. A total of 4 studies met the inclusion criteria and were included in the review.


Conclusion: Fluticasone propionate did not demonstrate a significant improvement in nasal congestion symptoms compared with placebo (p > 0.05). The use of intranasal fluticasone propionate during pregnancy did not affect adrenal function, with comparable S-cortisol and U-cortisol levels between the fluticasone and placebo groups (p > 0.05). Intranasal fluticasone propionate was shown to be safe for the fetus. Fetal growth parameters on ultrasound (femur length, biparietal diameter) and postnatal outcomes (gestational age at birth, birth weight, and Apgar score) did not differ significantly from those of the control group (p > 0.05).

Article Details

Keywords

Rhinosinusitis, pregnancy, topical steroids.

References

[1] Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi:10.4193/Rhin20.600
[2] Sedaghat AR. Chronic rhinosinusitis. Am Fam Physician. 2017;96(8):500-506.
[3] Namazy JA, Schatz M. Current guidelines for the management of asthma during pregnancy. Immunol Allergy Clin North Am. 2006;26(1):93-102. doi:10.1016/j.iac.2005.10.003 IF: 2.2 Q3 B3
[4] Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S103-S115. doi:10.1016/j.jaci.2009.12.989 IF: 11.2 Q1 B1
[5] Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc. 1988;9(5):545-554. doi:10.2500/108854188778965627 IF: 2.2 Q3 B3
[6] Namazy JA, Schatz M. Asthma and rhinitis during pregnancy. Mt Sinai J Med. 2011;78(5):661-670. doi:10.1002/msj.20284 IF: NA NA NA
[7] Namazy JA, Schatz M. The safety of intranasal steroids during pregnancy: a good start. J Allergy Clin Immunol. 2016;138(1):105-106. doi:10.1016/j.jaci.2016.04.026 IF: 11.2 Q1 B1
[8] Bérard A, Sheehy O, Kurzinger ML, Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol. 2016;138(1):97-104.e7. doi:10.1016/j.jaci.2016.01.021
[9] Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci. 2001;26(5):394-400. doi:10.1046/j.1365-2273.2001.00491.x
[10] Mabry RL. Intranasal steroid injection during pregnancy. South Med J. 1980;73(9):1176-1179. doi:10.1097/00007611-198009000-00004